{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:19:27Z","timestamp":1773209967492,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"DOI":"10.7759\/cureus.104968","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:27:56Z","timestamp":1773131276000},"source":"Crossref","is-referenced-by-count":0,"title":["Apremilast as an Adjuvant in Refractory Reactive Arthritis: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Noorussaba","family":"Arfeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivangi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushal","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12741","article-title":"Reactive arthritis","volume":"29","author":"Stavropoulos PG","year":"2015","unstructured":"Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C. Reactive arthritis. J Eur Acad Dermatol Venereol. 2015, 29:415-24. 10.1111\/jdv.12741","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740902769559","article-title":"Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000","volume":"38","author":"Savolainen E","year":"2009","unstructured":"Savolainen E, Kettunen A, N\u00e4rv\u00e4nen A, Kautiainen H, K\u00e4rkk\u00e4inen U, Luosuj\u00e4rvi R, Kaipiainen-Sepp\u00e4nen O. Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000. Scand J Rheumatol. 2009, 38:353-6. 10.1080\/03009740902769559","journal-title":"Scand J Rheumatol"},{"key":"ref3","article-title":"Similarity between chronic reactive arthritis and ankylosing spondylitis. A 32-35-year follow-up study","volume":"27","author":"Kaarela K","year":"2009","unstructured":"Kaarela K, J\u00e4ntti JK, Kotaniemi KM. Similarity between chronic reactive arthritis and ankylosing spondylitis. A 32-35-year follow-up study. Clin Exp Rheumatol. 2009, 27:325-8.","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.03.010","article-title":"Reactive arthritis: clinical aspects and medical management","volume":"35","author":"Carter JD","year":"2009","unstructured":"Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am. 2009, 35:21-44. 10.1016\/j.rdc.2009.03.010","journal-title":"Rheum Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.047","article-title":"Reiter's syndrome: the classic triad and more","volume":"59","author":"Wu IB","year":"2008","unstructured":"Wu IB, Schwartz RA. Reiter's syndrome: the classic triad and more. J Am Acad Dermatol. 2008, 59:113-21. 10.1016\/j.jaad.2008.02.047","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2298\/mpns1408222b","article-title":"Reiter's syndrome--disease of young men-- analysis of 312 patients","volume":"67","author":"Bojovi\u0107 J","year":"2014","unstructured":"Bojovi\u0107 J, Streli\u0107 N, Pavlica L. Reiter's syndrome--disease of young men-- analysis of 312 patients. Med Pregl. 2014, 67:222-30. 10.2298\/mpns1408222b","journal-title":"Med Pregl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes MB","year":"2005","unstructured":"Stokes MB, Foster K, Markowitz GS, et al.. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005, 20:1400-6. 10.1093\/ndt\/gfh832","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207963","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)","volume":"75","author":"Edwards CJ","year":"2016","unstructured":"Edwards CJ, Blanco FJ, Crowley J, et al.. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3). Ann Rheum Dis. 2016, 75:1065-73. 10.1136\/annrheumdis-2015-207963","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205056","article-title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","volume":"73","author":"Kavanaugh A","year":"2014","unstructured":"Kavanaugh A, Mease PJ, Gomez-Reino JJ, et al.. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis. 2014, 73:1020-6. 10.1136\/annrheumdis-2013-205056","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et's syndrome--a phase 2, placebo-controlled study","volume":"372","author":"Hatemi G","year":"2015","unstructured":"Hatemi G, Melikoglu M, Tunc R, et al.. Apremilast for Beh\u00e7et's syndrome--a phase 2, placebo-controlled study. N Engl J Med. 2015, 372:1510-8. 10.1056\/NEJMoa1408684","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2016.07.011","article-title":"Selective phosphodiesterase inhibitors: a new therapeutic option in inflammation and autoimmunity","volume":"12","author":"Hern\u00e1ndez-Fl\u00f3rez D","year":"2016","unstructured":"Hern\u00e1ndez-Fl\u00f3rez D, Valor L. Selective phosphodiesterase inhibitors: a new therapeutic option in inflammation and autoimmunity. Reumatol Clin. 2016, 12:303-6. 10.1016\/j.reuma.2016.07.011","journal-title":"Reumatol Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.8.564","article-title":"Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts","volume":"55","author":"Kingsley G","year":"1996","unstructured":"Kingsley G, Sieper J. Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis. 1996, 55:564-84. 10.1136\/ard.55.8.564","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson DT","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, et al.. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995, 38:727-35. 10.1002\/art.1780380602","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford Health Assessment Questionnaire: dimensions and practical applications","volume":"1","author":"Bruce B","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003, 1:20. 10.1186\/1477-7525-1-20","journal-title":"Health Qual Life Outcomes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer P","year":"2012","unstructured":"Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012, 83:1583-90. 10.1016\/j.bcp.2012.01.001","journal-title":"Biochem Pharmacol"},{"key":"ref16","article-title":"Otezla (apremilast), an oral PDE-4 inhibitor, receives FDA approval for the treatment of patients with active psoriatic arthritis and plaque psoriasis","volume":"8","author":"Fala L","year":"2015","unstructured":"Fala L. Otezla (apremilast), an oral PDE-4 inhibitor, receives FDA approval for the treatment of patients with active psoriatic arthritis and plaque psoriasis. Am Health Drug Benefits. 2015, 8:105-10.","journal-title":"Am Health Drug Benefits"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-17969-3_17","article-title":"Phosphodiesterase inhibitors in the treatment of inflammatory diseases","volume":"4","author":"Page CP","year":"2011","unstructured":"Page CP, Spina D. Phosphodiesterase inhibitors in the treatment of inflammatory diseases. Handb Exp Pharmacol. 2011, 4:391-414. 10.1007\/978-3-642-17969-3_17","journal-title":"Handb Exp Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464904-apremilast-as-an-adjuvant-in-refractory-reactive-arthritis-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:27:57Z","timestamp":1773131277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464904-apremilast-as-an-adjuvant-in-refractory-reactive-arthritis-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.104968","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}